These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4694626)

  • 1. Role of chlorpromazine in maintaining timing behavior in chronic schizophrenics.
    Angle HV
    Psychopharmacologia; 1973 Jan; 28(2):185-94. PubMed ID: 4694626
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorpromazine and body image. Effects on chronic schizophrenics.
    Cardone SS; Olson RE
    Arch Gen Psychiatry; 1969 May; 20(5):576-82. PubMed ID: 5777310
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics.
    Kaplan J; Dawson S; Vaughan T; Green R; Wyatt RJ
    Arch Gen Psychiatry; 1974 Jul; 31(1):62-6. PubMed ID: 4365280
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum tryptophan binding in chlorpromazine-treated chronic schizophrenics.
    Bender DA; Bamji AN
    J Neurochem; 1974 May; 22(5):805-9. PubMed ID: 4407100
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
    Gendron JL; Zimmermann RL; Schiele BC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):333-6. PubMed ID: 4197258
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.
    Cooper SF; Albert JM; Hillel J; Caille G
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):73-7. PubMed ID: 4632509
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of thioridazine tablets to chlorpromazine spansules in the maintenance care of chronic schizophrenics.
    Bartlett C
    Curr Ther Res Clin Exp; 1971 Feb; 13(2):100-6. PubMed ID: 4994211
    [No Abstract]   [Full Text] [Related]  

  • 8. Gradual reduction of neuroleptic drugs among chronic schizophrenics. A double-blind controlled study.
    Lonowski DJ; Sterling FE; Kennedy JC
    Acta Psychiatr Scand; 1978 Feb; 57(2):97-102. PubMed ID: 345749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the relative efficacy of Serenace and chlorpromazine in the treatment of chronic schizophrenics.
    Rompel H; Segal H
    J Int Med Res; 1978; 6(2):126-32. PubMed ID: 344086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine.
    Kiriike N; Uete T; Motomura K; Enomoto M; Murata K
    Biol Psychiatry; 1984 Mar; 19(3):417-22. PubMed ID: 6144330
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics.
    Freeman H
    Dis Nerv Syst; 1973; 34(6):289-93. PubMed ID: 4782285
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic therapy for chronic schizophrenia.
    Ayd FJ
    Dis Nerv Syst; 1972 Jan; 33(1):35-9. PubMed ID: 5059687
    [No Abstract]   [Full Text] [Related]  

  • 13. Loxapine: a double-blind comparison with chlorpromazine in acute schizophrenic patients.
    Steinbook RM; Goldstein BJ; Brauzer B; Moreno SS; Jacobson AF
    Curr Ther Res Clin Exp; 1973 Jan; 15(1):1-7. PubMed ID: 4631378
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of chlorpromazine on visual information processing in normal subjects.
    Spohn HE; Lacoursiere RB; Williams RO
    J Nerv Ment Dis; 1974 Sep; 159(3):198-204. PubMed ID: 4854747
    [No Abstract]   [Full Text] [Related]  

  • 15. Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication.
    Prien RF; Cole JO; Belkin NF
    Br J Psychiatry; 1969 Jun; 115(523):679-86. PubMed ID: 5806858
    [No Abstract]   [Full Text] [Related]  

  • 16. Methodological issues in psychopharmacological research.
    Davis JM; Hurt SW
    Am J Orthopsychiatry; 1977 Jul; 47(3):523-36. PubMed ID: 888926
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of chlorpromazine and trifluoperazine on the activity of chronic schizophrenics.
    Jones IH; Pikler N
    Br J Psychiatry; 1971 Nov; 119(552):545-6. PubMed ID: 4944663
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
    Kolivakis T; Azim H; Kingstone E
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparative study of butaperazine, chlorpromazine and placebo in chronic schizophrenics.
    Keskiner A; Itil TM; Todt N
    Psychosomatics; 1970; 11(2):120-6. PubMed ID: 4394278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.